With our new Maine Center for Biomedical Innovation, we also have the physical resources and expertise to commercialize innovative therapies and services.
The patented discovery comes from Novocell's recognized research & development programs to commercialize pluripotent stem cells for broad research and therapeutic uses, in particular, for an innovative cell therapy for the treatment of diabetes.